Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-32,000
Closed -$885K 482
2021
Q4
$885K Hold
32,000
0.1% 180
2021
Q3
$867K Hold
32,000
0.1% 176
2021
Q2
$900K Hold
32,000
0.1% 180
2021
Q1
$705K Hold
32,000
0.08% 210
2020
Q4
$598K Hold
32,000
0.06% 222
2020
Q3
$496K Sell
32,000
-13,007
-29% -$201K 0.06% 222
2020
Q2
$687K Sell
45,007
-18,862
-30% -$280K 0.09% 210
2020
Q1
$815K Buy
63,869
+42,503
+199% +$761K 0.12% 189
2019
Q4
$514K Buy
21,366
+2,387
+13% +$54.5K 0.04% 310
2019
Q3
$400K Sell
18,979
-21,760
-53% -$450K 0.04% 341
2019
Q2
$899K Buy
40,739
+10,107
+33% +$235K 0.06% 319
2019
Q1
$724K Buy
30,632
+2,314
+8% +$54K 0.06% 307
2018
Q4
$630K Sell
28,318
-3,374
-11% -$80.9K 0.05% 315
2018
Q3
$826K Buy
31,692
+17,564
+124% +$487K 0.02% 410
2018
Q2
$381K Hold
14,128
0.01% 523
2018
Q1
$366K Hold
14,128
0.01% 535
2017
Q4
$389K Hold
14,128
0.01% 589
2017
Q3
$317K Hold
14,128
0.01% 635
2017
Q2
$374K Buy
+14,128
New +$377K 0.01% 592

Other funds holding TBI

First Quadrant's TBI Position: Q1 2022 in Review

First Quadrant sold out of Trueblue (TBI) in Q1 2022, closing a stake of 32,000 shares — an estimated $885K sold.

First Quadrant first reported a position in TBI in Q2 2017 and held it in 19 quarters. The position peaked at $900K in Q2 2021. 183 funds tracked by Wall St. Rank hold TBI as of Q1 2022.

  • First Quadrant reported no remaining Trueblue position as of Q1 2022 after selling out during the quarter.
  • First Quadrant sold 32,000 Trueblue shares in Q1 2022, an estimated $885K.
  • First Quadrant first reported a position in Trueblue in Q2 2017 and held it in 19 quarters.
  • First Quadrant's Trueblue position peaked at $900K in Q2 2021.
  • 183 funds tracked by Wall St. Rank held Trueblue as of Q1 2022.

Based on First Quadrant's 13F filing for Q1 2022, filed 21 Apr 2022.